Summary Water suppressed proton nuclear magnetic resonance ('H NMR) spectroscopy of human plasma has been described as successful in detection of malignancy. We designed a prospective study to test the hypothesis that in vitro NMR spectroscopy has a high sensitivity for detecting early breast cancer. One hundred and thirty-five women were referred for breast biopsy due to abnormal mammograms. One hundred of these were recruited through a population-based mammography screening project. Sixty-nine of 135 women were found to have breast cancer and their average line width of the methyl and methylene resonance in the plasma were compared to those women who had a benign or normal histopathology in the biopsy and to the line width for 100 healthy subjects from the same population. Thus the biopsy group was subdivided into one group with malignant and another with benign or normal histological findings. The sample size was predetermined to 120 by power calculations. Our aim was to detect differences in line width of the same magnitude as that described by Fossel, with 80% power and a 5% significance level. One hundred of the women were referred directly from a mammography screening center. The screening was a population-based public health care program for mammography alone.
Fossel et al. have described the successful application of in vitro water-suppressed proton nuclear magnetic resonance ('H NMR) spectroscopy of human plasma for the detection of malignancy (1986) . They reported a statistically significantly narrower average line width of the methyl and methylene resonance in the plasma of patients with cancer than in healthy subjects. The water-suppressed proton spectrum of plasma contains resonances attributable to lipoprotein lipids. It is possible that a number of lipid alterations described in patients with cancer may change the distribution of low density and high density lipoproteins and thereby influence the line shape of those signals (Mims et al., 1989) .
However, Fossel's findings have never been fully supported by other investigations and most studies have shown a considerable overlap in the distribution of line widths between individuals with and without cancer (Okunieff et al., 1990) . A strong correlation has also been found between the line width and the serum triglyceride level (Mims et al., 1989; Okunieff et al., 1990) .
We designed a prospective study to To obtain a reference group that was not subject to preoperative psychological stress, 100 healthy subjects from the same population were enrolled from an ongoing populationbased screening study for primary hyperparathyroidism among women 50 years of age and older. All these women gave their informed consent.
Data collection
On the day before surgery the women in the biopsy group were asked whether they had had a malignant tumour earlier in life, whether they smoked, whether they were on a special diet, when 1-6 days before the NMR measurement. The plasma samples were coded so that the NMR laboratory was blinded to the women's disease status. No one at the NMR laboratory had access to information from the hospital regarding the study subject.
A Bruker AM 400 instrument ('H; 400 MHz) was used. Each plasma sample of ca 0.5 ml was diluted with 0.15 ml D20 (for locking). The probe temperature was adjusted to 21°C. Optimisation of the instrument was carried out according to the protocol of Fossel et al. (1986) . The water signal was presaturated for 4 s prior to applying a 900 pulse or an inversion/recovery sequence (Hartmann-Hahn) for obtaining the spectrum. The latter technique was used to remove the signals from all fast relaxing protons e.g., the peak from the lactate protons which coincides with the methylene protons. After processing, using a line-widening of 2 Hz, the spectra were baseline-corrected using a spline function. The line widths at half-height of the methylene and methyl signals were then measured with a ruler. The size of the mean value of these two line widths is a significant indication of the presence of cancer, according to Fossel et al. (1986) .
The processed data presented in this paper are extracted from the inversion/recovery experiments. However, control calculations of data from regular 90°-experiments lead to similar results and the same conclusion. (Table  II) .
In the biopsy group, the relationship between disease status (cancer or benign), triglyceride level, age and line width was analysed in greater detail (Table III ). The triglyceride level taken on its own correlated negatively with the line width, which is also illustrated in Figure 1 Among the 69 cancer cases, the possibility of correlations between the line width and the size and type of the tumour and nodal involvement were investigated (Table IV) . After correction for age and triglyceride level, no correlation was found (Table IV) . The ROC curves confirmed the impression that the line width was not helpful as a diagnostic marker. At the most beneficial cut point (line width = 39.7 Hz), the sensitivity was as low as 61 % and the percentage of false positives was 43% (Figure 2 ). The line width for the 20 women at the follow-up 3-4 months postoperatively was compared to their line widths preoperatively. A regression correction for age and triglycerides and a paired t-test confirmed that the differences were very small and that the line width primarily depended on the current level of serum triglycerides. did not improve the diagnostic accuracy of the line width.
The study design was rigorous and ideally suited to answer the question whether in vitro NMR spectroscopy can detect breast cancer in the preclinical stage. The study subjects comprised a consecutive sample from a population-based screening program. Almost all the patients with breast abnormalities were asymptomatic and the diagnosis of cancer in these cases was not established until after the operation -i.e., after the blood samples were drawn. Thus the patient's diagnosis was blind in relation not only to the NMR analysis but also to the person who drew the blood samples and took the history. We were able to adjust for the serum triglyceride level in every individual.
According to our results, NMR line width has virtually no power to detect early breast cancer. Although no one has systematically studied the domain of preclinical breast cancer, our results agree with those of several other investigators (Bell et al., 1987; Nicholson & Nicholson, 1987; Small & Hamilton, 1987; Buchthal et al., 1988; Berger et al., 1989; Herring et al., 1989; Engan et al., 1990; Otvos et al., 1991) .
No other study has included unselected controls from the same source population as the cases. Similar results which show that ROC analysis is of little diagnostic value have also been obtained by others (Otvos et al., 1991) . Two further reports (Peeling et al., 1988; Hofeler & Scheulen, 1989) credit in vitro NMR spectroscopy with a greater capacity to detect cancer but they still found a considerable overlap between the various patient groups (Peeling et al., 1988) , and inconsistent results when the experiment was repeated (Hofeler & Scheulen, 1989) . They did not determine the serum triglyceride levels (Peeling et al., 1988; Hofeler & Scheulen, 1989) .
We followed Fossel's laboratory methods carefully. The lack of a difference in line width in our investigation may be due to a low 'tumour burden' among the patients with cancer. This possibility is partially offset by the lack of correlation between a preoperative tumour burden and line width and by the lack of a significant change after removal of the primary tumour. Moreover, if the size of the breast cancer must be appreciably larger than in this study to be detected by NMR, this method would have little clinical value. The use of line width for distinguishing between benign and malignant disease would then fall short of other methods, such as mammography, cytology and clinical investigation. In summary in vitro NMR spectroscopy in our hands was not a useful diagnostic tool in patients with early breast
